This inventor holds 2 USPTO granted patents and 14 published patent applications and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2021-2025.
Company Filing History:
Years Active: 2021-2025
Title: The Innovative Contributions of Donald Jp Pinto
Introduction
Donald Jp Pinto is a notable inventor based in Churchville, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific factors involved in thromboembolic and inflammatory disorders. With a total of 2 patents, his work has the potential to impact medical treatments significantly.
Latest Patents
Donald Jp Pinto's latest patents include "Macrocycles as Factor XIa Inhibitors" and "Substituted Glycine Derived FXIa Inhibitors." The first patent provides compounds of Formula (I) that are selective Factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein. This invention also relates to pharmaceutical compositions comprising these compounds and methods of treating thromboembolic and/or inflammatory disorders using the same. The second patent similarly offers compounds of Formula (I) that serve as selective Factor XIa inhibitors or dual inhibitors of FXIa and plasma kallikrein, along with related pharmaceutical compositions and treatment methods.
Career Highlights
Donald Jp Pinto is currently associated with Bristol-Myers Squibb Company, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new therapeutic options that can improve patient outcomes in various medical conditions.
Collaborations
Throughout his career, Donald has collaborated with esteemed colleagues, including Leon M Smith, II and James R Corte. These partnerships have likely enhanced the scope and impact of his research and inventions.
Conclusion
Donald Jp Pinto's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work not only showcases his inventive spirit but also holds promise for improving treatments for thromboembolic and inflammatory disorders.